Hallucinogenic Drug Ibogaine Can Halt User’s Desire To Take Heroin

THE ORLANDO SENTINEL September 5, 1993 Sunday, 3 STAR SECTION: A SECTION; Pg. A12 LOAD-DATE-MDX: September 16, 1993 LENGTH: 671 words LANGUAGE: ENGLISH HEADLINE: DRUG’S SIDE-EFFECT: BLOCKING OF ADDICTION; SOME USERS CLAIM THE HALLUCINOGENIC DRUG IBOGAINE CAN HALT THEIR DESIRE TO TAKE HEROIN. BYLINE: Compiled From Wire Reports DATELINE: NEW …

Continue reading

Hallucinogen Being Studied As Treatment For Addiction

Copyright 1992 Globe Newspaper Company The Boston Globe November 9, 1992, Monday, City Edition SECTION: SCIENCE & TECHNOLOGY; Pg. 29 LENGTH: 1371 words HEADLINE: HALLUCINOGEN BEING STUDIED AS TREATMENT FOR ADDICTION; PHARMACOLOGY BYLINE: By Dolores Kong, Globe Staff BODY: In the urgent search for new treatments for cocaine and heroin …

Continue reading

Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to …

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC …

Continue reading

2003: Drug Policy Alliance Conference

The Drug Policy Alliance 2003 Biennial Conference Ibogaine Roundtable   [01:05 PM] Moderator: Howard Lotsof [01:10 PM] Returning Control of Ibogaine to Drug Users Howard S. Lotsof, Dora Weiner Foundation, Staten Island, NY Discoverer of ibogaine’s anti-addictive effects [01:20 PM] Ibogaine: Historical Review Kenneth R. Alper, MD, Associate Professor, NYU …

Continue reading

2004: Ibogaine – Rite of Passage

Ibogaine: Rite of Passage a Documentary Film about Ibogaine Ibogaine is a substance derived from the root of the African plant Tabernanthe iboga, which grows in Gabon. This sacred plant was originally used during spiritual initiation ceremonies of the Bwiti religion. In 1962 the anti-addictive properties of ibogaine were discovered …

Continue reading

Data Accrue on “Visionary” Agent to Interrupt Addiction

Science & Medicine: Data Accrue on “Visionary” Agent to Interrupt Addiction The Lancet [Volume 354, Number 9193] 27 November 1999 by Kelly Morris Few therapies exist for drug addiction, and unfortunately one agent that has shown promise– the plant alkaloid ibogaine–is mostly given in unsafe settings by addict self-help groups, …

Continue reading

Addiction Treatment Strives for Legitimacy

by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others, …

Continue reading

Ibogaine in the Treatment of Chemical Dependence Disorders

Ibogaine in the Treatment of Chemical Dependence Disorders: Clinical Perspectives Copyright © 1994, Howard S. Lotsof All Rights Reserved Reproduced by permission of: The Ibogaine Dossier (Original Publication: MAPS – Volume 5, Number 3, Winter 1994-95) Dedicated to the work of J. Bastiaans and N. Adriaans In memory of N. …

Continue reading

Ibogaine: A Novel Anti-Addictive Compound…

Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of …

Continue reading